 Henry Waxman |
Henry Waxman, who was a powerful Los Angeles Congressman, is working Washington for a Pennsylvania drug company that is positioning itself as the leader in opioid addiction treatment.
Braeburn Inc.’s new drug application for CAM2038 weekly and monthly buprenorphine formulations is currently under review by the Food and Drug Administration.
Democrat Waxman, who was involved in healthcare, environmental and technology issues, stepped down from Congress in 2015 after a 40-year career that was capped by chairing the Energy and Commerce Committee and Committee on Oversight and Government Reform.
Jeremy Sharp, who was deputy commissioner for policy planning, legislation and analysis at the FDA and counselor for science and public health for Secretaries Kathleen Sebelius and Sylvia Burwell, joins Waxman on the push for Braeburn.
In January, Braeburn received $110M in financing from a Wellington Management Co.-led group that included Deerfield Management, RA Capital Management, New Leaf Venture Partners, Rock Springs Capital and Apple Tree Partners.
Missy Edwards Strategies represents Shein Technology Group, the Los Angeles arm of the embattled Singapore-based “instant fashion” retailer.
Carlsbad, a north San Diego County city of 115K people, is looking for a firm to provide government relations and Sacramento lobbying services.
Gordon Sondland, who was US ambassador to the European Union under Donald Trump, has registered as a representative of Ukraine’s cabinet and ministers.
The Daschle Group is representing Santa Monica-based Stand with Hong Kong Action, an advocacy group that fights to end Chinese repression in Hong Kong.
McKinsey & Co. has reached out to Republican shop Harbinger Strategies to educate policymakers about the activities of the embattled management consultancy.
Have a comment? Send it to 
No comments have been submitted for this story yet.